Liquid Biopsy Market
Liquid Biopsy Market - Global Industry Assessment & Forecast
#
Pages:
142
Base Year:
2023
Jul - 2024
Format:
Report Code:
VMR-2009
Segments Covered
By
Product & Services Assay Kits, Instruments, Services
-
By
Circulating Biomarkers Circulating Tumor Cells, Circulating Tumor DNA (ctDNA), Circulating Tumor DNA (ctDNA) , Cell-free DNA (cfDNA), Extracellular Vesicles (EVS), Other Circulating Biomarkers
-
By
Clinical Applications Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring
-
By
Technology Multi-Gene Parallel Analysis using NGS, Single-Gene Analysis using PCR Microarrays
-
By
Application Cancer Applications, Non-Cancer Applications
-
By
Sample Type Blood, Other Sample Types
-
By
End User Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers, Other End Users
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 5.64 Billion |
 Revenue 2032:
|
USD 15.75 Billion |
 Revenue CAGR
(2024 - 2032): |
12.09% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Liquid Biopsy Market Segment Analysis
- Liquid Biopsy Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
- Assay Kits
- Instruments
- Services
- Liquid Biopsy Circulating Biomarkers Outlook (Revenue, USD Million, 2018 - 2030)
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Liquid Biopsy Clinical Applications Outlook (Revenue, USD Million, 2018 - 2030)
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Liquid Biopsy Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Liquid Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
- Cancer Applications
- Non-Cancer Applications
- Liquid Biopsy Sample Type Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Other Sample Types
- Liquid Biopsy End User Outlook (Revenue, USD Million, 2018 - 2030)
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
-
North America Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
-
North America Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
-
North America Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
-
North America Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
-
North America Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
-
North America Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- U.S.
- U.S. Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- U.S. Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- U.S. Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- U.S. Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- U.S. Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- U.S. Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- U.S. Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- U.S. Liquid Biopsy Market, by Product & Services
- Canada
- Canada Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Canada Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Canada Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Canada Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Canada Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- Canada Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- Canada Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Canada Liquid Biopsy Market, by Product & Services
-
Mexico
- Mexico Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Mexico Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Mexico Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Mexico Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Mexico Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- Mexico Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- Mexico Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Mexico Liquid Biopsy Market, by Product & Services
-
North America Liquid Biopsy Market, by Product & Services
- Europe
-
Europe Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
-
Europe Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
-
Europe Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
-
Europe Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
-
Europe Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
-
Europe Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
-
Europe Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- U. K.
- U.K. Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- U.K. Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- U.K. Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- U.K. Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- U.K. Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- U.K. Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- U.K. Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- U.K. Liquid Biopsy Market, by Product & Services
- France
- France Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- France Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- France Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- France Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- France Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- France Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- France Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- France Liquid Biopsy Market, by Product & Services
-
Germany
- Germany Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Germany Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Germany Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Germany Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Germany Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- Germany Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- Germany Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Germany Liquid Biopsy Market, by Product & Services
-
Italy
- Italy Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Italy Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Italy Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Italy Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Italy Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- Italy Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- Italy Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Italy Liquid Biopsy Market, by Product & Services
-
Spain
- Spain Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Spain Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Spain Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Spain Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Spain Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- Spain Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- Spain Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Spain Liquid Biopsy Market, by Product & Services
-
Rest of Europe
- Rest of Europe Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Rest of Europe Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Rest of Europe Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Rest of Europe Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Rest of Europe Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- Rest of Europe Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- Rest of Europe Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Rest of Europe Liquid Biopsy Market, by Product & Services
-
Europe Liquid Biopsy Market, by Product & Services
- Asia Pacific
-
Asia Pacific Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
-
Asia Pacific Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
-
Asia Pacific Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
-
Asia Pacific Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
-
Asia Pacific Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
-
Asia Pacific Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
-
Asia Pacific Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- China
- China Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- China Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- China Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- China Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- China Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- China Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- China Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- China Liquid Biopsy Market, by Product & Services
- Japan
- Japan Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Japan Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Japan Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Japan Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Japan Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- Japan Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- Japan Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Japan Liquid Biopsy Market, by Product & Services
-
Germany
- Germany Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Germany Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Germany Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Germany Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Germany Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- Germany Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- Germany Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Germany Liquid Biopsy Market, by Product & Services
-
India
- India Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- India Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- India Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- India Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- India Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- India Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- India Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- India Liquid Biopsy Market, by Product & Services
-
South Korea
- South Korea Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- South Korea Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- South Korea Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- South Korea Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- South Korea Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- South Korea Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- South Korea Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- South Korea Liquid Biopsy Market, by Product & Services
-
South East Asia
- South East Asia Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- South East Asia Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- South East Asia Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- South East Asia Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- South East Asia Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- South East Asia Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- South East Asia Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- South East Asia Liquid Biopsy Market, by Product & Services
-
Rest of Asia Pacific
- Rest of Asia Pacific Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Rest of Asia Pacific Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Rest of Asia Pacific Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Rest of Asia Pacific Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Rest of Asia Pacific Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- Rest of Asia Pacific Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- Rest of Asia Pacific Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Rest of Asia Pacific Liquid Biopsy Market, by Product & Services
-
Asia Pacific Liquid Biopsy Market, by Product & Services
- Latin America
-
Latin America Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
-
Latin America Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
-
Latin America Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
-
Latin America Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
-
Latin America Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
-
Latin America Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
-
Latin America Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Brazil
- Brazil Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Brazil Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Brazil Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Brazil Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Brazil Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- Brazil Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- Brazil Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Brazil Liquid Biopsy Market, by Product & Services
- Argentina
- Argentina Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Argentina Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Argentina Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Argentina Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Argentina Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- Argentina Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- Argentina Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Argentina Liquid Biopsy Market, by Product & Services
-
Rest of Latin America
- Rest of Latin America Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Rest of Latin America Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Rest of Latin America Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Rest of Latin America Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Rest of Latin America Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- Rest of Latin America Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- Rest of Latin America Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Rest of Latin America Liquid Biopsy Market, by Product & Services
-
Latin America Liquid Biopsy Market, by Product & Services
- Middle East & Africa
-
Middle East & Africa Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
-
Middle East & Africa Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
-
Middle East & Africa Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
-
Middle East & Africa Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
-
Middle East & Africa Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
-
Middle East & Africa Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
-
Middle East & Africa Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- GCC Countries
- GCC Countries Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- GCC Countries Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- GCC Countries Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- GCC Countries Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- GCC Countries Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- GCC Countries Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- GCC Countries Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- GCC Countries Liquid Biopsy Market, by Product & Services
- South Africa
- South Africa Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- South Africa Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- South Africa Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- South Africa Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- South Africa Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- South Africa Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- South Africa Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- South Africa Liquid Biopsy Market, by Product & Services
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Rest of Middle East & Africa Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Rest of Middle East & Africa Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Rest of Middle East & Africa Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Rest of Middle East & Africa Liquid Biopsy Market, by Application
- Cancer Applications
- Non-Cancer Applications
- Rest of Middle East & Africa Liquid Biopsy Market, by Sample Type
- Blood
- Other Sample Types
- Rest of Middle East & Africa Liquid Biopsy Market, by End User
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Rest of Middle East & Africa Liquid Biopsy Market, by Product & Services
-
Middle East & Africa Liquid Biopsy Market, by Product & Services
- North America
Vantage Market
Research | 29-Jul-2024
FAQ
Frequently Asked Question
What is the global demand for Liquid Biopsy in terms of revenue?
-
The global Liquid Biopsy valued at USD 5.64 Billion in 2023 and is expected to reach USD 15.75 Billion in 2032 growing at a CAGR of 12.09%.
Which are the prominent players in the market?
-
The prominent players in the market are Bio-Rad Laboratories, Biocept Inc., Guardant Health, Illumina Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Laboratory Corporation of America Holdings, MDxHealth SA, QIAGEN N.V., Thermo Fisher Scientific Inc..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 12.09% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Liquid Biopsy include
- Liquid biopsy offers many advantages over traditional tissue biopsy methods, driving its adoption in clinical practice
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Liquid Biopsy in 2023.
